INVESTOR RELATIONS
New Generation Nuclear Radioisotope Reactor Infrastructure to Power the Future of Cancer Diagnosis and Treatment
Addressing a $27B+ market gap in critical medical isotopes with a next-generation dual-site facility design and breakthrough fuel technology.
ALL TARGET REACTOR
EDEN’S UNIQUE
TECHNOLOGY
Our concept uses a simple, straightforward, and proven technology that is well developed and ready to be applied, with no technical showstoppers or hurdles to overcome.
Instead of using a large high-flux reactor to “drive” uranium loaded targets, we make the reactor core out of low-enriched uranium (LEU) targets. By using this method, the nuclear reactor is optimized to produce Mo-99, Lu-177, along with a variety of other medical isotopes.
ALL TARGET REACTOR
EDEN’S UNIQUE
TECHNOLOGY
Our concept uses a simple, straightforward, and proven technology that is well developed and ready to be applied, with no technical showstoppers or hurdles to overcome.
Instead of using a large high-flux reactor to “drive” uranium loaded targets, we make the reactor core out of low-enriched uranium (LEU) targets. By using this method, the nuclear reactor is optimized to produce Mo-99, Lu-177, along with a variety of other medical isotopes.
NUCLEAR REACTOR PRODUCED
MEDICAL ISOTOPES
Whether diagnosing the function of an organ, detecting cancer, or destroying cancerous cells, medical isotopes will continue to be vitally important to our healthcare system.
MO-99
LU-177
Other Medical Isotopes
NM, USA
TOP OF THE LINE
FACILITIES
Strategically selected location in a nuclear-friendly community with Waste Control Specialists (WCS) 3 miles away.
- Isotope Facility
- Reactor Facility
- Hot Cell Facility
NM, USA
TOP OF THE LINE
FACILITIES
Strategically selected location in a nuclear-friendly community with Waste Control Specialists (WCS) 3 miles away.
- Isotope Facility
- Reactor Facility
- Hot Cell Facility